Protocols
4 protocol(s) meet the specified criteria
Drug: ERBITUX
Protocol No.TitleStatus
201404139Phase I/II Trial of the Addition of PD 0332991 to Cetuximab in Patients with Incurable SCCHNOpen
LCCC1330A Phase II study of carboplatin, paclitaxel and cetuximab for patients with recurrent or metastatic squamous cell carcinoma of the head and neckOpen
LCCC1612P53 mutational status and circulating free HPV DNA for the management of HPV-associated Oropharyngeal Squamous Cell Cancers Open
NC-6004-008Phase I/II Clinical Trial of NC-6004 in Combination with 5-FU and Cetuximab as First-line Treatment in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of The Head and NeckOpen